Home Services Industry Services Press Releases About Us Blogs Report Store Contact us

Point Of Care Testing Market | Acumen Research and Consulting

Point of Care Testing Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030

Published : Nov 2022

Report ID: ARC1136

Pages : 250

Format : Point of Care Testing Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030

Summary Table of Content Customization Download Sample Infographics

CHAPTER 1. Industry Overview of Point of Care Testing Market

1.1. Definition and Scope

1.1.1. Definition of Point of Care Testing

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Point of Care Testing Market

1.2. Summary

1.2.1. Executive Summary

1.2.2. Point of Care Testing Market By Product

1.2.3. Point of Care Testing Market By Technology

1.2.4. Point of Care Testing Market By Prescription

1.2.5. Point of Care Testing Market By Application

1.2.6. Point of Care Testing Market By End-User

1.2.7. Point of Care Testing Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Point of Care Testing Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Point of Care Testing Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Regulatory Compliance

3.9. Competitive Landscape, 2021

3.9.1. Player Positioning Analysis

3.9.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Point of Care Testing Market By Product

4.1. Introduction

4.2. Point of Care Testing Revenue By Product

4.2.1. Point of Care Testing Revenue (USD Billion) and Forecast, By Product, 2018-2030

4.2.2. Glucose Monitoring

4.2.2.1. Glucose Monitoring Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.2.2. Strips

4.2.2.2.1. Strips Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.2.3. Meters

4.2.2.3.1. Meters Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.2.4. Lancets

4.2.2.4.1. Lancets Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.3. Cardiometabolic Testing Products

4.2.3.1. Cardiometabolic Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.3.2. Cardiac Marker Testing Products

4.2.3.2.1. Cardiac Marker Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.3.3. Blood Gas/Electrolytes Testing Products

4.2.3.3.1. Blood Gas/Electrolytes Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.3.4. HBA1C Testing Products

4.2.3.4.1. HBA1C Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.4. Infectious Disease Testing Products

4.2.4.1. Infectious Disease Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.4.2. Influenza Testing Products

4.2.4.2.1. Influenza Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.4.3. HIV Products Testing

4.2.4.3.1. HIV Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.4.4. Hepatitis C Testing Products

4.2.4.4.1. Hepatitis C Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.4.5. Sexually Transmitted Disease (STD) Testing Products

4.2.4.5.1. Sexually Transmitted Disease (STD) Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.4.6. Healthcare-Associated Infection (HAI) Testing Products

4.2.4.6.1. Healthcare-Associated Infection (HAI) Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.4.7. Respiratory Infection Testing Products

4.2.4.7.1. Respiratory Infection Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.4.8. Tropical Disease Testing Products

4.2.4.8.1. Tropical Disease Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.4.9. Other Infectious Diseases Testing Products

4.2.4.9.1. Other Infectious Diseases Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.5. Coagulation Testing Products

4.2.5.1. Coagulation Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.5.2. PT/INR Testing Products

4.2.5.2.1. PT/INR Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.5.3. Activated Clotting Time (ACT/APTT) Testing Products

4.2.5.3.1. Activated Clotting Time (ACT/APTT) Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.6. Pregnancy and Fertility Testing Products

4.2.6.1. Pregnancy and Fertility Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.6.2. Pregnancy Testing Products

4.2.6.2.1. Pregnancy Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.6.3. Fertility Testing Products

4.2.6.3.1. Fertility Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.7. Tumor/Cancer Marker Testing Products

4.2.7.1. Tumor/Cancer Marker Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.8. Urinalysis Testing Products

4.2.8.1. Urinalysis Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.9. Cholesterol Testing Products

4.2.9.1. Cholesterol Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.10. Hematology Testing Products

4.2.10.1. Hematology Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.11. Drug-of-Abuse (DoA) Testing Products

4.2.11.1. Drug-of-Abuse (DoA) Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.12. Fecal Occult Testing Products

4.2.12.1. Fecal Occult Testing Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.13. Other Products

4.2.13.1. Other Products Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 5. Point of Care Testing Market By Technology

5.1. Introduction

5.2. Point of Care Testing Revenue By Application

5.2.1. Point of Care Testing Revenue (USD Billion) and Forecast, By Application, 2018-2030

5.2.2. Lateral Flow Assays

5.2.2.1. Lateral Flow Assays Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.3. Dipsticks

5.2.3.1. Dipsticks Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.4. Microfluidics

5.2.4.1. Microfluidics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.5. Molecular Diagnostics

5.2.5.1. Molecular Diagnostics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.6. Immunoassays

5.2.6.1. Immunoassays Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.7. Agglutination Assays

5.2.7.1. Agglutination Assays Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.8. Flow-Through

5.2.8.1. Flow-Through Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.9. Solid Phase

5.2.9.1. Solid Phase Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.10. Biosensors

5.2.10.1. Biosensors Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 6. Point of Care Testing Market By Prescription

6.1. Introduction

6.2. Point of Care Testing Revenue By Prescription

6.2.1. Point of Care Testing Revenue (USD Billion) and Forecast, By Prescription, 2018-2030

6.2.2. OTC Testing

6.2.2.1. OTC Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.3. Prescription-Based Testing

6.2.3.1. Prescription-Based Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 7. Point of Care Testing Market By Application

7.1. Introduction

7.2. Point of Care Testing Revenue By Application

7.2.1. Point of Care Testing Revenue (USD Billion) and Forecast, By Application, 2018-2030

7.2.2. Cardio Metabolic Testing

7.2.2.1. Cardio Metabolic Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

7.2.3. Infectious Disease Testing

7.2.3.1. Infectious Disease Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

7.2.4. Nephrology Testing

7.2.4.1. Nephrology Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

7.2.5. Drug-of-Abuse (DoA) Testing

7.2.5.1. Drug-of-Abuse (DoA) Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

7.2.6. Blood Glucose Testing

7.2.6.1. Blood Glucose Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

7.2.7. Pregnancy Testing

7.2.7.1. Pregnancy Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

7.2.8. Cancer Biomarker Testing

7.2.8.1. Cancer Biomarker Testing Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

7.2.9. Other Applications

7.2.9.1. Other Applications Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 8. Point of Care Testing Market By End-User

8.1. Introduction

8.2. Point of Care Testing Revenue By End-User

8.2.1. Point of Care Testing Revenue (USD Billion) and Forecast, By End-User, 2018-2030

8.2.2. Hospitals & Clinics

8.2.2.1. Hospitals & Clinics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

8.2.3. Home-Care Settings

8.2.3.1. Home-Care Settings Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

8.2.4. Assisted Living Healthcare Facilities

8.2.4.1. Assisted Living Healthcare Facilities Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

8.2.5. Laboratories

8.2.5.1. Laboratories Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

8.2.6. Others

8.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 9. North America Point of Care Testing Market By Country

9.1. North America Point of Care Testing Market Overview

9.2. U.S.

9.2.1. U.S. Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

9.2.2. U.S. Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

9.2.3. U.S. Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

9.2.4. U.S. Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

9.2.5. U.S. Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

9.3. Canada

9.3.1. Canada Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

9.3.2. Canada Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

9.3.3. Canada Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

9.3.4. Canada Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

9.3.5. Canada Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

9.4. North America PEST Analysis

CHAPTER 10. Europe Point of Care Testing Market By Country

10.1. Europe Point of Care Testing Market Overview

10.2. U.K.

10.2.1. U.K. Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

10.2.2. U.K. Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

10.2.3. U.K. Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

10.2.4. U.K. Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

10.2.5. U.K. Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

10.3. Germany

10.3.1. Germany Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

10.3.2. Germany Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

10.3.3. Germany Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

10.3.4. Germany Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

10.3.5. Germany Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

10.4. France

10.4.1. France Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

10.4.2. France Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

10.4.3. France Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

10.4.4. France Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

10.4.5. France Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

10.5. Spain

10.5.1. Spain Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

10.5.2. Spain Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

10.5.3. Spain Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

10.5.4. Spain Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

10.5.5. Spain Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

10.6. Rest of Europe

10.6.1. Rest of Europe Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

10.6.2. Rest of Europe Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

10.6.3. Rest of Europe Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

10.6.4. Rest of Europe Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

10.6.5. Rest of Europe Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

10.7. Europe PEST Analysis

CHAPTER 11. Asia Pacific Point of Care Testing Market By Country

11.1. Asia Pacific Point of Care Testing Market Overview

11.2. China

11.2.1. China Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

11.2.2. China Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

11.2.3. China Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

11.2.4. China Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

11.2.5. China Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

11.3. Japan

11.3.1. Japan Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

11.3.2. Japan Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

11.3.3. Japan Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

11.3.4. Japan Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

11.3.5. Japan Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

11.4. India

11.4.1. India Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

11.4.2. India Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

11.4.3. India Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

11.4.4. India Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

11.4.5. India Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

11.5. Australia

11.5.1. Australia Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

11.5.2. Australia Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

11.5.3. Australia Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

11.5.4. Australia Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

11.5.5. Australia Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

11.6. South Korea

11.6.1. South Korea Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

11.6.2. South Korea Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

11.6.3. South Korea Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

11.6.4. South Korea Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

11.6.5. South Korea Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

11.7. Rest of Asia-Pacific

11.7.1. Rest of Asia-Pacific Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

11.7.2. Rest of Asia-Pacific Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

11.7.3. Rest of Asia-Pacific Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

11.7.4. Rest of Asia-Pacific Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

11.7.5. Rest of Asia-Pacific Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

11.8. Asia Pacific PEST Analysis

CHAPTER 12. Latin America Point of Care Testing Market By Country

12.1. Latin America Point of Care Testing Market Overview

12.2. Brazil

12.2.1. Brazil Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

12.2.2. Brazil Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

12.2.3. Brazil Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

12.2.4. Brazil Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

12.2.5. Brazil Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

12.3. Mexico

12.3.1. Mexico Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

12.3.2. Mexico Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

12.3.3. Mexico Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

12.3.4. Mexico Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

12.3.5. Mexico Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

12.4. Rest of Latin America

12.4.1. Rest of Latin America Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

12.4.2. Rest of Latin America Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

12.4.3. Rest of Latin America Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

12.4.4. Rest of Latin America Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

12.4.5. Rest of Latin America Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

12.5. Latin America PEST Analysis

CHAPTER 13. Middle East & Africa Point of Care Testing Market By Country 

13.1. Middle East & Africa Point of Care Testing Market Overview

13.2. GCC

13.2.1. GCC Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

13.2.2. GCC Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

13.2.3. GCC Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

13.2.4. GCC Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

13.2.5. GCC Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

13.3. South Africa

13.3.1. South Africa Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

13.3.2. South Africa Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

13.3.3. South Africa Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

13.3.4. South Africa Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

13.3.5. South Africa Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

13.4. Rest of Middle East & Africa

13.4.1. Rest of Middle East & Africa Point of Care Testing Revenue (USD Billion) and Forecast By Product, 2018-2030

13.4.2. Rest of Middle East & Africa Point of Care Testing Revenue (USD Billion) and Forecast By Technology, 2018-2030

13.4.3. Rest of Middle East & Africa Point of Care Testing Revenue (USD Billion) and Forecast By Prescription, 2018-2030

13.4.4. Rest of Middle East & Africa Point of Care Testing Revenue (USD Billion) and Forecast By Application, 2018-2030

13.4.5. Rest of Middle East & Africa Point of Care Testing Revenue (USD Billion) and Forecast By End-User, 2018-2030

13.5. Middle East & Africa PEST Analysis

CHAPTER 14. Player Analysis Of Point of Care Testing Market

14.1. Point of Care Testing Market Company Share Analysis

14.2. Competition Matrix

14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

14.2.2. New Product Launches and Product Enhancements

14.2.3. Mergers And Acquisition In Global Point of Care Testing Market

14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 15. Company Profile

15.1. Abbott Laboratories

15.1.1. Company Snapshot

15.1.2. Business Overview

15.1.3. Financial Overview

15.1.3.1. Revenue (USD Billion), 2021

15.1.3.2. Abbott Laboratories 2021 Point of Care Testing Business Regional Distribution

15.1.4. Product /Service and Specification

15.1.5. Recent Developments & Business Strategy

15.2. Becton Dickinson (BD)

15.3. Biomerieux SA

15.4. Danaher Corp.

15.5. F. Hoffmann-La Roche Ltd.

15.6. Instrumentation Laboratory

15.7. Nova Biomedical

15.8. Qiagen

15.9. Siemens Healthcare AG

15.10. Trividia Health, Inc.

15.11. Zoetis, Inc.

Frequently Asked Questions

What is the size of global point of care testing market in 2021?

The market size of point of care testing market in 2021 was accounted to be USD 33.7 Billion.

What is the CAGR of global point of care testing market during forecast period of 2022 to 2030?

The projected CAGR of point of care testing market during the analysis period of 2022 to 2030 is 8.8%.

Which are the key players operating in the market?

The prominent players of the global point of care testing market include Abbott Laboratories, Becton Dickinson (BD), Biomerieux SA, Danaher Corp., F. Hoffmann-La Roche Ltd., Instrumentation Laboratory, Nova Biomedical, Qiagen, Siemens Healthcare AG, Trividia Health, Inc., and Zoetis, Inc.

Which region held the dominating position in the global point of care testing market?

North America held the dominating point of care testing during the analysis period of 2022 to 2030.

Which region registered the fastest growing CAGR for the forecast period of 2022 to 2030?

Asia-Pacific region exhibited fastest growing CAGR for point of care testing during the analysis period of 2022 to 2030.

What are the current trends and dynamics in the global point of care testing market?

Growing prevalence of infectious diseases, surging favorable government policies, and increasing number of CLAI-waived POC tests drives the growth of global point of care testing market.

Which product held the maximum share in 2021?

Based on product, infectious diseases segment is expected to hold the maximum share point of care testing market.

Select Licence Type

Single User

US$ 4500

Multi User

US$ 7000

Excel Datapack

US$ 2000

Why Acumen Research And Consulting

100%

Customer Satisfaction

24x7

Availability - we are always there when you need us

200+

Fortune 50 Companies trust Acumen Research and Consulting

80%

of our reports are exclusive and first in the industry

100%

more data and analysis

1000+

reports published till date